Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Occup Environ Med ; 37(9): 1093-101, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8528717

RESUMEN

Worker exposure to N,N-dimethylacetamide (DMAC) in an acrylic fiber manufacturing facility was measured, over a 1-year study period, by full-shift (12 hours) personal air monitoring for DMAC and by biological monitoring for levels of DMAC, N-methylacetamide (MMAC), and acetamide in spot urine samples. Ninety-three of 127 male workers in seven job classifications in the solution preparation and spinning departments of the plant were monitored on the second consecutive workday after at least 3 days off for the first 10 months of the study and on both the first and second days during the study's final 2 months. Postshift urinary MMAC levels were significantly correlated (P < .0001, r2 = .54) with DMAC in air levels. An air level of 6.7 ppm 12-hour time-weighted average (TWA) corresponded to a urine MMAC level of 62 mg/g creatinine in a postshift spot urine sample obtained after the second consecutive workday. To minimize exposure misclassification due to variability in the regression relationship, a level of 35 mg MMAC/g creatinine in a postshift spot urine sample was recommended as a biomonitoring index. Postshift urine MMAC levels did not appear to plateau at higher air levels, nor did it appear that the DMAC demethylation metabolic mechanisms became saturated at threshold limit value (TLV)-level air-exposure levels. Urine MMAC levels in postshift samples obtained the second workday appeared to be greater than levels in postshift first-day samples, but the number of days until this postshift level would plateau could not be determined from this study.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Acetamidas/efectos adversos , Contaminantes Ocupacionales del Aire/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Monitoreo del Ambiente , Enfermedades Profesionales/inducido químicamente , Exposición Profesional/efectos adversos , Solventes/efectos adversos , Acetamidas/farmacocinética , Adulto , Contaminantes Ocupacionales del Aire/farmacocinética , Enfermedad Hepática Inducida por Sustancias y Drogas/orina , Creatinina/orina , Estudios de Factibilidad , Humanos , Masculino , Concentración Máxima Admisible , Persona de Mediana Edad , Enfermedades Profesionales/diagnóstico , Enfermedades Profesionales/orina , Factores de Riesgo , Solventes/farmacocinética
2.
J Occup Environ Med ; 37(9): 1102-7, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8528718

RESUMEN

Worker exposure to N,N-dimethylacetamide (DMAC) in an acrylic fiber manufacturing facility was measured, over a 1-year study period, by full-shift (12 hours) personal air monitoring for DMAC and biological monitoring for levels of DMAC, N-methylacetamide (MMAC) and acetamide in post-shift spot urine samples. Evidence of liver toxicity was assessed by serum clinical chemistry tests (serum levels of total bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and gamma-glutamyl transpeptase) at least once during the study period for all 127 male workers in the two study departments and for 217 male in-plant controls with no previous or current exposure to DMAC. If a worker's biomonitoring results exceeded one of two "trigger" values established for the study (60 mg MMAC/g creatinine or 136 mg DMAC equivalent/g creatinine), additional serum clinical chemistry tests were conducted at weekly intervals for 3 weeks. DMAC-exposed workers were classified as either high exposure, if one or more biomonitoring result exceeded one of the trigger values, or unspecified exposure if none of them did. Control-group employees were classified as no-exposure. Mean DMAC in air levels for the high- and unspecified-exposure groups appeared to differ (geometric mean DMAC in air levels of 1.9 and 1.3 ppm 12-hour time-weighted average, respectively). No significant DMAC exposure-related trends in hepatic serum clinical chemistry results were detected. Neither transient increases in serum analyte levels after a "high" biomonitoring result (one that exceeded a trigger value) nor an elevated mean level over the study period when compared with in-plant controls were observed.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Contaminantes Ocupacionales del Aire/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Monitoreo del Ambiente/métodos , Pruebas de Función Hepática , Enfermedades Profesionales/inducido químicamente , Exposición Profesional/efectos adversos , Solventes/efectos adversos , Adulto , Contaminantes Ocupacionales del Aire/farmacocinética , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Relación Dosis-Respuesta a Droga , Humanos , Masculino , Concentración Máxima Admisible , Persona de Mediana Edad , Enfermedades Profesionales/sangre , Enfermedades Profesionales/diagnóstico , Factores de Riesgo , Solventes/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA